Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data from an International Observational Cohort.
Diagnostic assessment in giant cell arteritis (GCA) is rapidly changing as vascular imaging becomes more available. The study objective was to determine if clinical subsets of GCA have distinct profiles or reflect differential diagnostic assessment. Patients were recruited from an international cohort and divided into four subsets based on a temporal artery (TA) abnormality [positive TA biopsy (TAB) or halo-sign on TA ultrasound (TA-US)] and/or evidence on imaging of large-vessel (LV) involvement: 1) both TA abnormality and LV involvement [TA(+)/LV(+) GCA]; 2) TA abnormality without large-vessel involvement [TA(+)/LV(-) GCA]; 3) large-vessel involvement without TA abnormality [TA(-)/LV(+) GCA]; and 4) clinically-diagnosed GCA without large-vessel involvement or TA abnormality [TA(-)/LV(-) GCA]. 941 patients with GCA were recruited from 72 international study sites. Most patients had multiple forms of diagnostic assessment, including TAB (n=704, 75%); TA-US (n=328, 35%); and LV-imaging (n=534, 57%). Assessment confirmed GCA for 66% TAB, 79% TA-US, and 40% of LV-imaging studies. GCA subsets had distinct profiles independent of diagnostic assessment strategies. TA(+)/LV(-) was the most common subset (51%) with a high burden of cranial ischemia. TA(-)/LV(-) (26%) had a high prevalence of cranial ischemia and musculoskeletal symptoms. TA(-)/LV(+) (12%) had prevalent upper extremity vascular abnormalities and a low prevalence of vision loss. TA(+)/LV(+) (11%) was older with a high prevalence of cranial ischemia, constitutional symptoms, and elevated acute phase reactants. Vascular imaging is increasingly incorporated into the diagnostic assessment of GCA and identifies clinical subsets of patients based on involvement of temporal and extracranial arteries.